This article is part of the supplement: Proceedings of the 2009 Drug Discovery for Neurodegeneration Conference
Proceedings
Characteristics of compounds that cross the blood-brain barrier
BMC Neurology 2009, 9(Suppl 1):S3 doi:10.1186/1471-2377-9-S1-S3
Accesses
- Last 30 days: 991 accesses
- Last 365 days: 10453 accesses
- All time: 17438 accesses

